Gunilla Anders Ekström
Director/Board Member at CORLINE BIOMEDICAL AB
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Håkan Gunnar Engqvist | M | 52 | 10 years | |
| Maria Strömme | M | 54 |
Disruptive Materials AB
 Disruptive Materials AB Chemicals: Major DiversifiedProcess Industries Disruptive Materials AB manufactures mesoporous magnesium carbonate. It focuses on commercializing the material Upsalite that can be used in applications such as desiccant for humidity control, pharmaceutics, adsorbent for waste handling, thermal and acoustic insulation, cosmetics, adsorbent in ink jet paper,and bio material applications. The company was founded by Johan A. V. Gómez de la Torre, Maria Strømme, Lars-Erik Mattias Karls, and Sara Kristina Frykstrand Ångström in December 2011 and is headquartered in Uppsala, Sweden.
Disruptive Pharma AB
 Disruptive Pharma AB Pharmaceuticals: MajorHealth Technology Disruptive Pharma AB is a pharmaceutical company based in Uppsala, Sweden, with a passion for innovation in drug products. The Swedish company has perfected the groundbreaking mesoporous magnesium carbonate (mmc) drug delivery technology, which makes it easier to develop amorphous drug candidates. By combining the mmc formulation technology with drug compounds, they can enhance existing products or assist in formulating new therapies. Disruptive Pharma seeks commercial partnership or licensing to industry partners within the drug improvement business area. The company was founded in 2018 by Maria Strömme, and the CEO is Peter Åsberg. | 13 years |
| Claus Elsborg Olesen | M | 50 | 8 years | |
| Urban Paulsson | M | 60 |
Gesynta Pharma AB
 Gesynta Pharma AB Pharmaceuticals: MajorHealth Technology Gesynta Pharma AB develops and manufactures novel oral treatments for patients with chronic inflammatory conditions. The company was founded by Gunilla Anders Ekström, Charlotte Elisabet Edenius, Urban Paulsson, Ralf Morgenstern, Per-Johan Göte Jakobsson and Patric Stenberg in 2017 and is headquartered in Solna, Sweden. | 7 years |
| Gunnar Magnus Modee Persson | M | 64 |
Karolinska Institutet
| 30 years |
| Sara Mangsbo | M | - |
Strike Pharma AB
 Strike Pharma AB Miscellaneous Commercial ServicesCommercial Services Strike Pharma AB is a Swedish company that specializes in developing therapeutic vaccines for solid tumors. The company is based in Uppsala, Sweden and was founded in 2020 by Pierre Dönnes and Sara Mangsbo. The company utilizes ADAC technology to create personalized immunotherapy for their patients. Mårten Winge has been the CEO of the company since 2021. | 4 years |
| Göran Tornling | M | 77 |
AnaMar AB
 AnaMar AB Pharmaceuticals: MajorHealth Technology AnaMar AB develops drugs and provides research services for chronic joint diseases. It focuses on the discovery, development and commercialization of novel therapeutic strategies to treat debilitating inflammation and pain. The company was founded in 1998 and is headquartered in Lund, Sweden.
Gesynta Pharma AB
Gesynta Pharma AB Pharmaceuticals: MajorHealth Technology Gesynta Pharma AB develops and manufactures novel oral treatments for patients with chronic inflammatory conditions. The company was founded by Gunilla Anders Ekström, Charlotte Elisabet Edenius, Urban Paulsson, Ralf Morgenstern, Per-Johan Göte Jakobsson and Patric Stenberg in 2017 and is headquartered in Solna, Sweden.
Karolinska Institutet
| - |
| Lars-Erik Mattias Karls | M | 49 |
Disruptive Materials AB
Disruptive Materials AB Chemicals: Major DiversifiedProcess Industries Disruptive Materials AB manufactures mesoporous magnesium carbonate. It focuses on commercializing the material Upsalite that can be used in applications such as desiccant for humidity control, pharmaceutics, adsorbent for waste handling, thermal and acoustic insulation, cosmetics, adsorbent in ink jet paper,and bio material applications. The company was founded by Johan A. V. Gómez de la Torre, Maria Strømme, Lars-Erik Mattias Karls, and Sara Kristina Frykstrand Ångström in December 2011 and is headquartered in Uppsala, Sweden. | 13 years |
| Peter Sjöstrand | M | 78 |
Disruptive Materials AB
Disruptive Materials AB Chemicals: Major DiversifiedProcess Industries Disruptive Materials AB manufactures mesoporous magnesium carbonate. It focuses on commercializing the material Upsalite that can be used in applications such as desiccant for humidity control, pharmaceutics, adsorbent for waste handling, thermal and acoustic insulation, cosmetics, adsorbent in ink jet paper,and bio material applications. The company was founded by Johan A. V. Gómez de la Torre, Maria Strømme, Lars-Erik Mattias Karls, and Sara Kristina Frykstrand Ångström in December 2011 and is headquartered in Uppsala, Sweden.
Karolinska Institutet
| - |
| Denise Goode | F | 66 |
AnaMar AB
AnaMar AB Pharmaceuticals: MajorHealth Technology AnaMar AB develops drugs and provides research services for chronic joint diseases. It focuses on the discovery, development and commercialization of novel therapeutic strategies to treat debilitating inflammation and pain. The company was founded in 1998 and is headquartered in Lund, Sweden. | 9 years |
| Ralf Morgenstern | M | - |
Gesynta Pharma AB
Gesynta Pharma AB Pharmaceuticals: MajorHealth Technology Gesynta Pharma AB develops and manufactures novel oral treatments for patients with chronic inflammatory conditions. The company was founded by Gunilla Anders Ekström, Charlotte Elisabet Edenius, Urban Paulsson, Ralf Morgenstern, Per-Johan Göte Jakobsson and Patric Stenberg in 2017 and is headquartered in Solna, Sweden. | 7 years |
| Gisela Marie Sitbon | M | 66 | 2 years | |
| Fredrik Carlsson | M | - | 13 years | |
| Patric Stenberg | M | - |
Gesynta Pharma AB
Gesynta Pharma AB Pharmaceuticals: MajorHealth Technology Gesynta Pharma AB develops and manufactures novel oral treatments for patients with chronic inflammatory conditions. The company was founded by Gunilla Anders Ekström, Charlotte Elisabet Edenius, Urban Paulsson, Ralf Morgenstern, Per-Johan Göte Jakobsson and Patric Stenberg in 2017 and is headquartered in Solna, Sweden. | 7 years |
| Peter Holm | M | 50 | 8 years | |
| Ulf Simonsen | M | 61 | 8 years | |
| Johan Wieslander | M | 64 | 9 years | |
| Mikael Søndergaard Thomsen | M | 56 | 8 years | |
| Annette Colin Lövgren | F | 59 | 3 years | |
| Leonard Daun | M | - | - | |
| Charlotte Elisabet Edenius | M | 66 |
Gesynta Pharma AB
Gesynta Pharma AB Pharmaceuticals: MajorHealth Technology Gesynta Pharma AB develops and manufactures novel oral treatments for patients with chronic inflammatory conditions. The company was founded by Gunilla Anders Ekström, Charlotte Elisabet Edenius, Urban Paulsson, Ralf Morgenstern, Per-Johan Göte Jakobsson and Patric Stenberg in 2017 and is headquartered in Solna, Sweden. | 7 years |
| Ulf Ljungberg | M | - |
AnaMar AB
AnaMar AB Pharmaceuticals: MajorHealth Technology AnaMar AB develops drugs and provides research services for chronic joint diseases. It focuses on the discovery, development and commercialization of novel therapeutic strategies to treat debilitating inflammation and pain. The company was founded in 1998 and is headquartered in Lund, Sweden. | 9 years |
| Pierre Dönnes | M | - |
Strike Pharma AB
Strike Pharma AB Miscellaneous Commercial ServicesCommercial Services Strike Pharma AB is a Swedish company that specializes in developing therapeutic vaccines for solid tumors. The company is based in Uppsala, Sweden and was founded in 2020 by Pierre Dönnes and Sara Mangsbo. The company utilizes ADAC technology to create personalized immunotherapy for their patients. Mårten Winge has been the CEO of the company since 2021. | 4 years |
| Klas Kärre | M | 70 |
Karolinska Institutet
| - |
| Gustav Ingemar Kihlström | M | 71 | 9 years | |
| Thomas Perlmann | M | - |
Karolinska Institutet
| - |
| Magnus Nilsson | M | 68 | 4 years | |
| Hans Lennart Rudolf Wigzell | M | 86 |
Karolinska Institutet
| 29 years |
| Anna Martling | M | 55 |
Karolinska Institutet
| - |
| Anders Olof Adolf Ekblom | M | 70 |
AnaMar AB
AnaMar AB Pharmaceuticals: MajorHealth Technology AnaMar AB develops drugs and provides research services for chronic joint diseases. It focuses on the discovery, development and commercialization of novel therapeutic strategies to treat debilitating inflammation and pain. The company was founded in 1998 and is headquartered in Lund, Sweden.
Karolinska Institutet
| 10 years |
| Tomas Lifvendahl | M | - | 2 years | |
| Henrik Kristian Moltke | M | 66 | 8 years | |
| Susana Borrás | F | - |
Karolinska Institutet
| - |
| Anders Blanck | M | - |
Karolinska Institutet
| - |
| Per Magnus Gerde | M | - |
Karolinska Institutet
| - |
| Hans Ehrsson | M | - |
Karolinska Institutet
| - |
| Lars Olson | M | - |
Karolinska Institutet
| - |
| Anna-Karin Edstedt Bonamy | M | 50 |
Karolinska Institutet
| 10 years |
| Björn Allan Beermann | M | 83 |
Karolinska Institutet
| - |
| Olle Kämpe | M | 68 |
Karolinska Institutet
| - |
| Han Jing Xie | M | 54 |
Karolinska Institutet
| - |
| Peter Hjelmström | M | 51 |
Karolinska Institutet
| - |
| Allan Wehnert | M | - | 4 years | |
| Joakim Tedroff | M | 63 |
Karolinska Institutet
| - |
| Jan Matthew Balmanno Carlstedt-Duke | M | 71 |
Karolinska Institutet
| - |
| Magnus Sjoegren | M | - |
Karolinska Institutet
| - |
| Rune Toftgard | M | - |
Karolinska Institutet
| - |
| Kerstin Uvnäs Moberg | M | 80 |
Karolinska Institutet
| - |
| Gunnar Olof Olsson | M | 71 |
Gesynta Pharma AB
Gesynta Pharma AB Pharmaceuticals: MajorHealth Technology Gesynta Pharma AB develops and manufactures novel oral treatments for patients with chronic inflammatory conditions. The company was founded by Gunilla Anders Ekström, Charlotte Elisabet Edenius, Urban Paulsson, Ralf Morgenstern, Per-Johan Göte Jakobsson and Patric Stenberg in 2017 and is headquartered in Solna, Sweden. | - |
| Tord Stefan Erik Arver | M | 72 |
Karolinska Institutet
| - |
| Hans Hassle | M | - |
Karolinska Institutet
| - |
| Magnus Jaderberg | M | - |
Karolinska Institutet
| - |
| Carani Sanjeevi | M | 66 |
Karolinska Institutet
| 28 years |
| Johan Edvard Lundin | M | 60 |
Karolinska Institutet
| 12 years |
| Ewa Björling | M | 63 |
Karolinska Institutet
| - |
| Lena Von Koch | F | - |
Karolinska Institutet
| - |
| Marie Wickman-Chanteraeu | M | 69 |
Karolinska Institutet
| - |
| Scott Boyer | M | 62 |
Karolinska Institutet
| - |
| Bengt Ingemar Samuelsson | M | 90 |
Karolinska Institutet
| - |
| Lars Ährlund-Richter | M | 72 |
Karolinska Institutet
| - |
| Rolf Valter Rikard Kiessling | M | 76 |
Karolinska Institutet
| 30 years |
| Jacob Uno Stanley Gunterberg | M | 57 |
Disruptive Pharma AB
Disruptive Pharma AB Pharmaceuticals: MajorHealth Technology Disruptive Pharma AB is a pharmaceutical company based in Uppsala, Sweden, with a passion for innovation in drug products. The Swedish company has perfected the groundbreaking mesoporous magnesium carbonate (mmc) drug delivery technology, which makes it easier to develop amorphous drug candidates. By combining the mmc formulation technology with drug compounds, they can enhance existing products or assist in formulating new therapies. Disruptive Pharma seeks commercial partnership or licensing to industry partners within the drug improvement business area. The company was founded in 2018 by Maria Strömme, and the CEO is Peter Åsberg. | - |
| Roger William Gunnarsson | M | 77 |
Gesynta Pharma AB
Gesynta Pharma AB Pharmaceuticals: MajorHealth Technology Gesynta Pharma AB develops and manufactures novel oral treatments for patients with chronic inflammatory conditions. The company was founded by Gunilla Anders Ekström, Charlotte Elisabet Edenius, Urban Paulsson, Ralf Morgenstern, Per-Johan Göte Jakobsson and Patric Stenberg in 2017 and is headquartered in Solna, Sweden. | - |
| Lars-Olof Hansson | M | 80 |
Karolinska Institutet
| 26 years |
| Bo Angelin | M | 73 |
Karolinska Institutet
| - |
| Andris Kreicbergs | M | - |
Karolinska Institutet
| - |
| Sven-Erik Dahlén | M | - |
Karolinska Institutet
| - |
| Jonas Karl Olaf Brambeck | M | 66 |
Gesynta Pharma AB
Gesynta Pharma AB Pharmaceuticals: MajorHealth Technology Gesynta Pharma AB develops and manufactures novel oral treatments for patients with chronic inflammatory conditions. The company was founded by Gunilla Anders Ekström, Charlotte Elisabet Edenius, Urban Paulsson, Ralf Morgenstern, Per-Johan Göte Jakobsson and Patric Stenberg in 2017 and is headquartered in Solna, Sweden. | - |
| Jonas Christopher Frisén | M | 58 |
Karolinska Institutet
| - |
| Per M. Almqvist | M | - |
Karolinska Institutet
| - |
| Lars Fredrik Sunnanväder | M | - | 19 years | |
| Per Axel Tomas Södersten | M | 79 |
Karolinska Institutet
| - |
| Stig Gösta Ollmar | M | 78 |
Karolinska Institutet
| 27 years |
| Madeleine Olsson-Eriksson | M | 79 |
Karolinska Institutet
| - |
| Bo-Ragnar Tolf | M | 74 |
Karolinska Institutet
| - |
| Matti Sällberg | M | 63 |
Karolinska Institutet
| 24 years |
| Bernd Seizinger | M | 67 |
Karolinska Institutet
| - |
| Josef M. Miller | M | - |
Karolinska Institutet
| - |
| Håkan Elmqvist | M | - |
Karolinska Institutet
| - |
| Håkan Mellstedt | M | 82 |
Karolinska Institutet
| 25 years |
| Graham Lappin | M | - |
Karolinska Institutet
| - |
| Roger Franklin | M | 45 |
Gesynta Pharma AB
Gesynta Pharma AB Pharmaceuticals: MajorHealth Technology Gesynta Pharma AB develops and manufactures novel oral treatments for patients with chronic inflammatory conditions. The company was founded by Gunilla Anders Ekström, Charlotte Elisabet Edenius, Urban Paulsson, Ralf Morgenstern, Per-Johan Göte Jakobsson and Patric Stenberg in 2017 and is headquartered in Solna, Sweden. | - |
| Pär Nordlund | M | 66 |
Karolinska Institutet
| 19 years |
| Eva Andersson-Dubin | M | - |
Karolinska Institutet
| - |
| Hans Wiksell | M | - |
Karolinska Institutet
| - |
| Gert Auer | M | - |
Karolinska Institutet
| - |
| David Rikard Martinsson Holmdahl | M | 71 |
Karolinska Institutet
| 16 years |
| John Arne Øvretveit | M | - |
Karolinska Institutet
| - |
| Ulf de Faire | M | - |
Karolinska Institutet
| - |
| Jan Anders Holgersson | M | - |
Karolinska Institutet
| - |
| Mona Ståhle | M | - |
Karolinska Institutet
| - |
| Torkel Klingberg | M | - |
Karolinska Institutet
| - |
| Lars Gunnar Lannfelt | M | 75 |
Karolinska Institutet
| 31 years |
| Edvard Smith | M | 73 |
Karolinska Institutet
| - |
| Erik Johan Frostegård | M | 65 |
Karolinska Institutet
| - |
| Klas Gosta Wiman | M | - |
Karolinska Institutet
| - |
| Lajos Gunnar Németh | M | 72 |
Karolinska Institutet
| 21 years |
| Sten Nilsson | M | 76 |
Karolinska Institutet
| - |
| Sven Fredrik Lindskog | M | 71 |
Karolinska Institutet
| - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Per-Johan Göte Jakobsson | M | 59 |
Gesynta Pharma AB
Gesynta Pharma AB Pharmaceuticals: MajorHealth Technology Gesynta Pharma AB develops and manufactures novel oral treatments for patients with chronic inflammatory conditions. The company was founded by Gunilla Anders Ekström, Charlotte Elisabet Edenius, Urban Paulsson, Ralf Morgenstern, Per-Johan Göte Jakobsson and Patric Stenberg in 2017 and is headquartered in Solna, Sweden. | - |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Sweden | 93 | 93.00% |
| Denmark | 8 | 8.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Gunilla Anders Ekström
- Personal Network